NEO

#2405
NeoGenomics, Inc.
8.35 USD
+4.37%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
8.35
8.35
年范围
4.72
13.74
日变化
+4.37%
每月变动
+3.99%
6个月变化
-12.11%
年变化
-13.20%
前一天收盘价
8.00
开盘价
8.35
买价
卖价
最低价
8.35
High
8.35
交易量
75
展开完整图表

Financials

概览 声明 统计
每季度 年度
  • Market Capitalization 1.08 B
  • Employee 2 500
  • Founded 2002
  • CEO Christopher M. Smith
  • Website www.neogenomics.com
  • Headquarter Nevada, United States
  • FIGI BBG000BKH263
  • Industry Technology
总收入
净利润
每股基本收益（基本 EPS）
总债务
自由现金流
现金及现金等价物
市盈率
-14
市销率
2.07

NeoGenomics Inc

NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization, flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics. Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas.

新闻